JP2000290184A - 経鼻投与製剤 - Google Patents
経鼻投与製剤Info
- Publication number
- JP2000290184A JP2000290184A JP11095033A JP9503399A JP2000290184A JP 2000290184 A JP2000290184 A JP 2000290184A JP 11095033 A JP11095033 A JP 11095033A JP 9503399 A JP9503399 A JP 9503399A JP 2000290184 A JP2000290184 A JP 2000290184A
- Authority
- JP
- Japan
- Prior art keywords
- group
- substituted
- unsubstituted
- compound
- examples
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP11095033A JP2000290184A (ja) | 1999-04-01 | 1999-04-01 | 経鼻投与製剤 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP11095033A JP2000290184A (ja) | 1999-04-01 | 1999-04-01 | 経鼻投与製剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2000290184A true JP2000290184A (ja) | 2000-10-17 |
| JP2000290184A5 JP2000290184A5 (https=) | 2006-05-18 |
Family
ID=14126786
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP11095033A Pending JP2000290184A (ja) | 1999-04-01 | 1999-04-01 | 経鼻投与製剤 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2000290184A (https=) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1769791A3 (en) * | 2001-07-19 | 2007-07-11 | Isis Innovation Limited | Treatment of Alzheimer's disease with cell cycle inhibitors |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1988007045A1 (fr) * | 1987-03-09 | 1988-09-22 | Kyowa Hakko Kogyo Co., Ltd. | Derives de la substance physiologiquement active k-252 |
| JPH02503915A (ja) * | 1987-05-22 | 1990-11-15 | ダンバイオシスト ユーケー リミテッド | 吸収促進した投与製剤 |
| JPH07242550A (ja) * | 1994-03-02 | 1995-09-19 | Teijin Ltd | 二次性副甲状腺機能亢進症治療剤 |
| WO1997049406A1 (en) * | 1996-06-25 | 1997-12-31 | Cephalon, Inc. | Use of k-252a derivative for the treatment of peripheral or central nerve disorders, and cytokine overproduction |
-
1999
- 1999-04-01 JP JP11095033A patent/JP2000290184A/ja active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1988007045A1 (fr) * | 1987-03-09 | 1988-09-22 | Kyowa Hakko Kogyo Co., Ltd. | Derives de la substance physiologiquement active k-252 |
| JPH02503915A (ja) * | 1987-05-22 | 1990-11-15 | ダンバイオシスト ユーケー リミテッド | 吸収促進した投与製剤 |
| JPH07242550A (ja) * | 1994-03-02 | 1995-09-19 | Teijin Ltd | 二次性副甲状腺機能亢進症治療剤 |
| WO1997049406A1 (en) * | 1996-06-25 | 1997-12-31 | Cephalon, Inc. | Use of k-252a derivative for the treatment of peripheral or central nerve disorders, and cytokine overproduction |
| JP2000514420A (ja) * | 1996-06-25 | 2000-10-31 | セファロン・インコーポレイテッド | 末梢または中枢神経障害およびサイトカイン過剰産生の治療のためのk―252a誘導体の使用 |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1769791A3 (en) * | 2001-07-19 | 2007-07-11 | Isis Innovation Limited | Treatment of Alzheimer's disease with cell cycle inhibitors |
| US8343926B2 (en) | 2001-07-19 | 2013-01-01 | Isis Innovation Ltd. | Therapeutic strategies for prevention and treatment of alzheimer's disease |
| US8921321B2 (en) | 2001-07-19 | 2014-12-30 | Isis Innovation Ltd. | Therapeutic strategies for prevention and treatment of alzheimer's disease |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1891956B1 (en) | Solubilization preparation | |
| ES2825700T3 (es) | Derivados de pirimidina sustituidos útiles en el tratamiento de enfermedades autoinmunitarias | |
| US9642848B2 (en) | Sublingual naloxone spray | |
| ES2700473T3 (es) | Biodisponibilidad cerebral mejorada de galantamina mediante formulaciones seleccionadas y administración transmucosa de profármacos lipofílicos | |
| JP2003505403A (ja) | 経鼻抗痙攣組成物及び調節方法 | |
| TWI763632B (zh) | 用於重症治療時之鎮靜方法及非口服調配物 | |
| US9125924B2 (en) | Compositions and methods for treating spinocerebellar ataxia | |
| TWI718158B (zh) | 藥學組成物 | |
| WO2017002030A1 (en) | Stable liquid formulations of melphalan | |
| US20050153999A1 (en) | Pharmaceutical compositions | |
| ES2377352T3 (es) | Nuevas composiciones a base de taxoides | |
| CZ20032752A3 (cs) | Přípravky pro nasální aplikaci, obsahující imidazotriazinon | |
| JP3927954B2 (ja) | カンプトテシン誘導体含有水性製剤およびそれを凍結乾燥した医薬組成物 | |
| EP2753302B1 (en) | Pharmaceutical composition of tapentadol | |
| JP2000290184A (ja) | 経鼻投与製剤 | |
| US12324811B2 (en) | Intranasal formulation | |
| WO2001047542A1 (en) | Vancomycin preparations | |
| BG62197B1 (bg) | Антимигренно средство за интраназално приложение | |
| JP2022136242A (ja) | エピナスチン又はその塩を含有する花粉破裂抑制剤 | |
| US20130101647A1 (en) | Pharmaceutical composition in which solubility of partially soluble tricyclic derivative is improved | |
| JP2000219628A (ja) | アラトロフロキサシンの予め混合した注射用組成物 | |
| US7572833B2 (en) | Drug composition comprising dipeptidyl aldehyde derivative | |
| US20230270714A1 (en) | Salvinorin compositions | |
| JP2002037745A (ja) | 水溶性の難・低吸収性薬物のバイオアベイラビリティ改善技術 | |
| JP6706988B2 (ja) | ボルテゾミブを含有する医薬組成物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20060324 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20060324 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20091006 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20100331 |